MIRA Pharmaceuticals (MIRA) Competitors $0.93 +0.02 (+2.21%) Closing price 04:00 PM EasternExtended Trading$0.94 +0.01 (+1.61%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MIRA vs. CLSD, AADI, BYSI, IKNA, MURA, FBRX, GRI, ALGS, APLT, and VTVTShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Clearside Biomedical (CLSD), Aadi Bioscience (AADI), BeyondSpring (BYSI), Ikena Oncology (IKNA), Mural Oncology (MURA), Forte Biosciences (FBRX), GRI Bio (GRI), Aligos Therapeutics (ALGS), Applied Therapeutics (APLT), and vTv Therapeutics (VTVT). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Clearside Biomedical Aadi Bioscience BeyondSpring Ikena Oncology Mural Oncology Forte Biosciences GRI Bio Aligos Therapeutics Applied Therapeutics vTv Therapeutics MIRA Pharmaceuticals (NASDAQ:MIRA) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Which has stronger valuation and earnings, MIRA or CLSD? MIRA Pharmaceuticals has higher earnings, but lower revenue than Clearside Biomedical. Clearside Biomedical is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$11.98M-$0.56-1.68Clearside Biomedical$7.70M8.30-$32.49M-$0.45-1.87 Does the MarketBeat Community believe in MIRA or CLSD? Clearside Biomedical received 365 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 67.28% of users gave Clearside Biomedical an outperform vote. CompanyUnderperformOutperformMIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo VotesClearside BiomedicalOutperform Votes36867.28% Underperform Votes17932.72% Which has more volatility & risk, MIRA or CLSD? MIRA Pharmaceuticals has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500. Comparatively, Clearside Biomedical has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Do analysts rate MIRA or CLSD? MIRA Pharmaceuticals presently has a consensus price target of $14.00, indicating a potential upside of 1,389.36%. Clearside Biomedical has a consensus price target of $5.33, indicating a potential upside of 532.66%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe MIRA Pharmaceuticals is more favorable than Clearside Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is MIRA or CLSD more profitable? MIRA Pharmaceuticals has a net margin of 0.00% compared to Clearside Biomedical's net margin of -413.83%. Clearside Biomedical's return on equity of 0.00% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -337.44% -280.58% Clearside Biomedical -413.83%N/A -92.90% Does the media refer more to MIRA or CLSD? In the previous week, Clearside Biomedical had 3 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 6 mentions for Clearside Biomedical and 3 mentions for MIRA Pharmaceuticals. Clearside Biomedical's average media sentiment score of 1.42 beat MIRA Pharmaceuticals' score of 0.22 indicating that Clearside Biomedical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MIRA Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Clearside Biomedical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of MIRA or CLSD? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are held by institutional investors. 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Comparatively, 9.2% of Clearside Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryMIRA Pharmaceuticals and Clearside Biomedical tied by winning 9 of the 18 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.40M$7.22B$5.81B$8.40BDividend YieldN/A2.80%4.76%3.97%P/E Ratio-1.666.2024.9419.16Price / SalesN/A188.07375.08111.39Price / CashN/A65.6738.0534.62Price / Book3.136.417.284.27Net Income-$11.98M$139.72M$3.19B$246.70M7 Day Performance-7.39%-3.74%-3.23%-3.77%1 Month Performance-16.81%-9.45%-7.10%-6.90%1 Year Performance-5.05%-12.69%12.20%3.67% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.1588 of 5 stars$0.93+2.2%$14.00+1,405.4%-12.5%$15.40MN/A-1.662Short Interest ↑News CoverageGap UpCLSDClearside Biomedical3.2044 of 5 stars$0.89-6.4%$5.33+499.9%-43.0%$67.43M$7.70M-1.9830Upcoming EarningsShort Interest ↓Positive NewsAADIAadi Bioscience1.2638 of 5 stars$2.73-2.3%$1.67-38.8%+19.8%$67.31M$24.35M-1.2040News CoverageBYSIBeyondSpringN/A$1.72-3.9%N/A+12.0%$67.13M$1.75M0.0080Gap DownIKNAIkena Oncology2.6674 of 5 stars$1.39flat$3.00+115.8%-12.2%$67.08M$9.16M-1.1370Upcoming EarningsShort Interest ↑News CoverageMURAMural Oncology3.309 of 5 stars$3.88-4.3%$16.00+312.9%-36.4%$65.95MN/A-0.42119News CoverageGap DownFBRXForte Biosciences3.7137 of 5 stars$10.01-8.9%$23.58+135.7%+26,434.0%$63.93MN/A-0.615Positive NewsGap UpGRIGRI Bio2.7499 of 5 stars$7.16+1.4%$195.50+2,632.4%-95.8%$63.89MN/A0.001Gap DownHigh Trading VolumeALGSAligos Therapeutics4.0491 of 5 stars$17.73-4.8%$75.00+323.0%-48.7%$63.65M$15.53M-1.3390Upcoming EarningsShort Interest ↑News CoverageGap DownAPLTApplied Therapeutics4.372 of 5 stars$0.54+1.9%$6.10+1,029.6%-93.5%$62.83M$-212,000.00-0.3430Upcoming EarningsVTVTvTv Therapeutics2.0252 of 5 stars$19.65-2.7%$35.00+78.2%+10.0%$62.67M$1M-4.349Analyst ForecastNews CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Clearside Biomedical Competitors Aadi Bioscience Competitors BeyondSpring Competitors Ikena Oncology Competitors Mural Oncology Competitors Forte Biosciences Competitors GRI Bio Competitors Aligos Therapeutics Competitors Applied Therapeutics Competitors vTv Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MIRA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts